ABG Sundal Collier acted as Sole bookrunner in the SEK 25m directed share issue in FluoGuide A/S

The board of directors of FluoGuide has, based on the authorization granted by the annual general meeting on 9 February 2021 resolved on a directed share issue of 495,000 shares at a subscription price of SEK 50.50. The Company will receive gross proceeds of SEK 24,997,500 from the Directed Share Issue. The Directed Share Issue was subscribed by a number of Swedish and international institutional investors, which included, among others A/S Arbejdernes Landsbank, Linc AB, OP Fund Management-Nordic Micro Cap Fund and Eastbridge.
The net proceeds of the Directed Share Issue are intended to co-finance a phase II study in less aggressive brain cancers (meningioma and low grade glioma) and provide flexibility post the two phase II results for using FG001 to guide surgery of high grade glioma and lung cancer. The phase III program for FG001 in brain cancer is planned to be initiated in 2023.
Morten Albrechtsen, CEO of FluoGuide comments: “We are very pleased with the support from current and new institutional investors for this transaction. This transaction is very important for FluoGuide giving flexibility which is essential in the current highly uncertain market”.